Spire Wealth Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-105
Closed -$10.3K 2360
2025
Q2
$10.3K Sell
105
-1
-0.9% -$95 ﹤0.01% 1710
2025
Q1
$9.82K Buy
106
+1
+1% +$92 ﹤0.01% 1839
2024
Q4
$9.53K Hold
105
﹤0.01% 1845
2024
Q3
$10.1K Buy
105
+1
+1% +$98 ﹤0.01% 1629
2024
Q2
$9.55K Hold
104
﹤0.01% 1649
2024
Q1
$9.59K Buy
104
+8
+8% +$750 ﹤0.01% 1725
2023
Q4
$9.1K Hold
96
﹤0.01% 1784
2023
Q3
$8.97K Sell
96
-37
-28% -$3.42K ﹤0.01% 1765
2023
Q2
$12.2K Sell
133
-22
-14% -$1.8K ﹤0.01% 1747
2023
Q1
$11.4K Sell
155
-92
-37% -$7.96K ﹤0.01% 1794
2022
Q4
$21K Buy
247
+210
+568% +$18.9K ﹤0.01% 1344
2022
Q3
$4K Sell
37
-97
-72% -$11.6K ﹤0.01% 1773
2022
Q2
$14K Sell
134
-7
-5% -$894 ﹤0.01% 1789
2022
Q1
$24K Hold
141
﹤0.01% 1733
2021
Q4
$23K Buy
141
+16
+13% +$2.57K ﹤0.01% 2060
2021
Q3
$19K Hold
125
﹤0.01% 1868
2021
Q2
$31K Hold
125
﹤0.01% 1677
2021
Q1
$8K Buy
+125
New +$35.3K ﹤0.01% 2465

Other funds holding AMED

Spire Wealth Management's AMED Position: Q3 2025 in Review

Spire Wealth Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 105 shares — an estimated $10.3K sold.

Spire Wealth Management first reported a position in AMED in Q1 2021 and held it in 18 quarters. The position peaked at $31K in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Spire Wealth Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Spire Wealth Management sold 105 Amedisys shares in Q3 2025, an estimated $10.3K.
  • Spire Wealth Management first reported a position in Amedisys in Q1 2021 and held it in 18 quarters.
  • Spire Wealth Management's Amedisys position peaked at $31K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Spire Wealth Management's 13F filing for Q3 2025, filed 23 Oct 2025.